• Olaf Bodamer MD - PhD, Therapeutic targets (IRB approved research project, actively enrolling)
• Professor Hannelore Ehrenreich, Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Göttingen, GERMANY: a study on the effect of EPO, in mouse model at the moment, based on the observation that In adult mice hippocampi, erythropoietin (EPO) expression drives the differentiation of new neurons, independent of DNA synthesis, and increases dendritic spine density
• Sophie Nambot, MD – PhD, Clinical trial with Lithium, Dijon , France, in the process of approval
TBR1